These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12730125)

  • 1. Endothelial dysfunction and LOX-1: forty years from muscle to endothelium.
    Masaki T
    Circ Res; 2003 May; 92(8):819-20. PubMed ID: 12730125
    [No Abstract]   [Full Text] [Related]  

  • 2. C-reactive protein enhances LOX-1 expression in human aortic endothelial cells: relevance of LOX-1 to C-reactive protein-induced endothelial dysfunction.
    Li L; Roumeliotis N; Sawamura T; Renier G
    Circ Res; 2004 Oct; 95(9):877-83. PubMed ID: 15472120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II increases the expression of lectin-like oxidized low-density lipoprotein receptor-1 in human vascular smooth muscle cells via a lipoxygenase-dependent pathway.
    Limor R; Kaplan M; Sawamura T; Sharon O; Keidar S; Weisinger G; Knoll E; Naidich M; Stern N
    Am J Hypertens; 2005 Mar; 18(3):299-307. PubMed ID: 15797645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vascular smooth muscle cells in coronary heart disease].
    Yoshioka S; Tsukamoto T; Chihara K
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():80-5. PubMed ID: 12734957
    [No Abstract]   [Full Text] [Related]  

  • 5. [LOX-1: the oxidized LDL receptor expressed in vascular endothelial cells].
    Sawamura T
    Seikagaku; 2002 May; 74(5):365-76. PubMed ID: 12073608
    [No Abstract]   [Full Text] [Related]  

  • 6. Essential role of cytoplasmic sequences for cell-surface sorting of the lectin-like oxidized LDL receptor-1 (LOX-1).
    Chen M; Sawamura T
    J Mol Cell Cardiol; 2005 Sep; 39(3):553-61. PubMed ID: 15935375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelium and smooth muscle: trophic interactions and potential for therapeutic intervention.
    Schachter M
    J Hum Hypertens; 1990 Oct; 4 Suppl 4():17-20; discussion 20-1. PubMed ID: 2283651
    [No Abstract]   [Full Text] [Related]  

  • 8. Stress and vascular responses: endothelial dysfunction via lectin-like oxidized low-density lipoprotein receptor-1: close relationships with oxidative stress.
    Sakurai K; Sawamura T
    J Pharmacol Sci; 2003 Mar; 91(3):182-6. PubMed ID: 12686739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin inhibits ox-LDL-mediated LOX-1 expression and metalloproteinase-1 in human coronary endothelial cells.
    Mehta JL; Chen J; Yu F; Li DY
    Cardiovasc Res; 2004 Nov; 64(2):243-9. PubMed ID: 15485683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in the development of hypertensive organ damage.
    Ando K; Fujita T
    Clin Exp Nephrol; 2004 Sep; 8(3):178-82. PubMed ID: 15480893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lectin-like oxidized low-density lipoprotein receptor and its role in atherosclerosis.
    Cilingiroglu M; Ozer K
    Curr Atheroscler Rep; 2005 Mar; 7(2):103-7. PubMed ID: 15727724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-LOX-1 rescues endothelial function in coronary arterioles in atherosclerotic ApoE knockout mice.
    Xu X; Gao X; Potter BJ; Cao JM; Zhang C
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):871-7. PubMed ID: 17272755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct vasoprotection by aspirin: a significant bonus to antiplatelet activity?
    Kojda G
    Cardiovasc Res; 2004 Nov; 64(2):192-4. PubMed ID: 15485676
    [No Abstract]   [Full Text] [Related]  

  • 14. Overexpression of lectin-like oxidized low-density lipoprotein receptor-1 induces intramyocardial vasculopathy in apolipoprotein E-null mice.
    Inoue K; Arai Y; Kurihara H; Kita T; Sawamura T
    Circ Res; 2005 Jul; 97(2):176-84. PubMed ID: 15961718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atorvastatin reduces platelet-oxidized-LDL receptor expression in hypercholesterolaemic patients.
    Puccetti L; Sawamura T; Pasqui AL; Pastorelli M; Auteri A; Bruni F
    Eur J Clin Invest; 2005 Jan; 35(1):47-51. PubMed ID: 15638819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis of vascular cells by oxidized LDL: involvement of caspases and LOX-1 and its implication in atherosclerotic plaque rupture.
    Kume N; Kita T
    Circ Res; 2004 Feb; 94(3):269-70. PubMed ID: 14976136
    [No Abstract]   [Full Text] [Related]  

  • 17. Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet.
    Mehta JL; Sanada N; Hu CP; Chen J; Dandapat A; Sugawara F; Satoh H; Inoue K; Kawase Y; Jishage K; Suzuki H; Takeya M; Schnackenberg L; Beger R; Hermonat PL; Thomas M; Sawamura T
    Circ Res; 2007 Jun; 100(11):1634-42. PubMed ID: 17478727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nitric oxide and vascular effects of lipoproteins: cellular and molecular mechanisms].
    Markov KhM
    Patol Fiziol Eksp Ter; 2006; (3):2-7. PubMed ID: 17002039
    [No Abstract]   [Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor alpha ligands activate transcription of lectin-like oxidized low density lipoprotein receptor-1 gene through GC box motif.
    Hayashida K; Kume N; Minami M; Inui-Hayashida A; Mukai E; Toyohara M; Kita T
    Biochem Biophys Res Commun; 2004 Oct; 323(3):1116-23. PubMed ID: 15381115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LOX-1 and atherosclerosis: proof of concept in LOX-1-knockout mice.
    Morawietz H
    Circ Res; 2007 Jun; 100(11):1534-6. PubMed ID: 17556664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.